These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 7526723)

  • 1. On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations.
    Suster S; Wong TY
    Am J Dermatopathol; 1994 Aug; 16(4):355-63. PubMed ID: 7526723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms.
    Requena L; Sangueza OP
    J Am Acad Dermatol; 1997 Dec; 37(6):887-919; quiz 920-2. PubMed ID: 9418757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokeratin expression in epithelioid vascular neoplasms.
    Gray MH; Rosenberg AE; Dickersin GR; Bhan AK
    Hum Pathol; 1990 Feb; 21(2):212-7. PubMed ID: 1689691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombomodulin as a marker of vascular and lymphatic tumours.
    Appleton MA; Attanoos RL; Jasani B
    Histopathology; 1996 Aug; 29(2):153-7. PubMed ID: 8872149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell "densities" in vascular proliferations: a preliminary study of pyogenic granuloma, portwine stain, cavernous hemangioma, cherry angioma, Kaposi's sarcoma, and malignant hemangioendothelioma.
    Hagiwara K; Khaskhely NM; Uezato H; Nonaka S
    J Dermatol; 1999 Sep; 26(9):577-86. PubMed ID: 10535252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: report of 145 cases and review of putative immunohistologic markers of endothelial differentiation.
    DeYoung BR; Swanson PE; Argenyi ZB; Ritter JH; Fitzgibbon JF; Stahl DJ; Hoover W; Wick MR
    J Cutan Pathol; 1995 Jun; 22(3):215-22. PubMed ID: 7593814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical identification of factor VIII-related antigen in endothelial cells of cutaneous lesions of alleged vascular nature.
    Burgdorf WH; Mukai K; Rosai J
    Am J Clin Pathol; 1981 Feb; 75(2):167-71. PubMed ID: 6781328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostaining for CD31 and CD34 in Kaposi sarcoma.
    Russell Jones R; Orchard G; Zelger B; Wilson Jones E
    J Clin Pathol; 1995 Nov; 48(11):1011-6. PubMed ID: 8543622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B72.3 and CD34 immunoreactivity in malignant epithelioid soft tissue tumors. Adjuncts in the recognition of endothelial neoplasms.
    Sirgi KE; Wick MR; Swanson PE
    Am J Surg Pathol; 1993 Feb; 17(2):179-85. PubMed ID: 7678485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staining for factor VIII related antigen and Ulex europaeus agglutinin I (UEA-I) in 230 tumours. An assessment of their specificity for angiosarcoma and Kaposi's sarcoma.
    Leader M; Collins M; Patel J; Henry K
    Histopathology; 1986 Nov; 10(11):1153-62. PubMed ID: 3100411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ulex europaeus I lectin as a marker for tumors derived from endothelial cells.
    Miettinen M; Holthofer H; Lehto VP; Miettinen A; Virtanen I
    Am J Clin Pathol; 1983 Jan; 79(1):32-6. PubMed ID: 6401381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia.
    Traweek ST; Kandalaft PL; Mehta P; Battifora H
    Am J Clin Pathol; 1991 Jul; 96(1):25-31. PubMed ID: 1712541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas.
    Poblet E; Gonzalez-Palacios F; Jimenez FJ
    Virchows Arch; 1996 Jul; 428(4-5):217-21. PubMed ID: 8764929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QBEnd/10: a new immunostain for the routine diagnosis of Kaposi's sarcoma.
    Sankey EA; More L; Dhillon AP
    J Pathol; 1990 Jul; 161(3):267-71. PubMed ID: 2391587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary vascular tumors of lymph nodes other than Kaposi's sarcoma. Analysis of 39 cases and delineation of two new entities.
    Chan JK; Frizzera G; Fletcher CD; Rosai J
    Am J Surg Pathol; 1992 Apr; 16(4):335-50. PubMed ID: 1373579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms.
    Requena L; Sangueza OP
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):143-75; quiz 176-8. PubMed ID: 9486670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eruptive epithelioid hemangioendothelioma with spindle cells.
    Kanik AB; Hall JD; Bhawan J
    Am J Dermatopathol; 1995 Dec; 17(6):612-7. PubMed ID: 8599479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Eruptive Epithelioid Hemangiomas: A Subset of Cutaneous Cellular Epithelioid Hemangioma With Expression of FOS-B.
    Llamas-Velasco M; Kempf W; Cota C; Fernández-Figueras MT; Lee J; Ferrara G; Sander C; Shapiro PE; Requena L; Kutzner H
    Am J Surg Pathol; 2019 Jan; 43(1):26-34. PubMed ID: 29266025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma.
    Arai E; Kuramochi A; Tsuchida T; Tsuneyoshi M; Kage M; Fukunaga M; Ito T; Tada T; Izumi M; Shimizu K; Hirose T; Shimizu M
    J Cutan Pathol; 2006 Jul; 33(7):492-7. PubMed ID: 16872472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial markers in malignant vascular tumours of the liver: superiority of QB-END/10 over von Willebrand factor and Ulex europaeus agglutinin 1.
    Anthony PP; Ramani P
    J Clin Pathol; 1991 Jan; 44(1):29-32. PubMed ID: 1705261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.